176 related articles for article (PubMed ID: 32107283)
1. Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification.
Trilla-Fuertes L; Ghanem I; Gámez-Pozo A; Maurel J; G-Pastrián L; Mendiola M; Peña C; López-Vacas R; Prado-Vázquez G; López-Camacho E; Zapater-Moros A; Heredia V; Cuatrecasas M; García-Alfonso P; Capdevila J; Conill C; García-Carbonero R; Ramos-Ruiz R; Fortes C; Llorens C; Nanni P; Fresno Vara JÁ; Feliu J
Mol Cell Proteomics; 2020 Apr; 19(4):690-700. PubMed ID: 32107283
[TBL] [Abstract][Full Text] [Related]
2. Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma.
Herfs M; Longuespée R; Quick CM; Roncarati P; Suarez-Carmona M; Hubert P; Lebeau A; Bruyere D; Mazzucchelli G; Smargiasso N; Baiwir D; Lai K; Dunn A; Obregon F; Yang EJ; Pauw E; Crum CP; Delvenne P
J Pathol; 2017 Mar; 241(4):522-533. PubMed ID: 27976366
[TBL] [Abstract][Full Text] [Related]
3. Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
Trilla-Fuertes L; Gámez-Pozo A; Nogué M; Busquier I; Arias F; López-Campos F; Fernández-Montes A; Ruiz A; Velázquez C; Martín-Bravo C; Pérez-Ruiz E; Asensio E; Hernández-Yagüe X; Rodrigues A; Ghanem I; López-Vacas R; Hafez A; Arias P; Dapía I; Solís M; Dittmann A; Ramos R; Llorens C; Maurel J; Campos-Barros Á; Fresno Vara JÁ; Feliu J
Cancer; 2023 Aug; 129(16):2581-2592. PubMed ID: 37096763
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
Van Damme N; Deron P; Van Roy N; Demetter P; Bols A; Van Dorpe J; Baert F; Van Laethem JL; Speleman F; Pauwels P; Peeters M
BMC Cancer; 2010 May; 10():189. PubMed ID: 20459770
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention.
Bernardi MP; Ngan SY; Michael M; Lynch AC; Heriot AG; Ramsay RG; Phillips WA
Lancet Oncol; 2015 Dec; 16(16):e611-21. PubMed ID: 26678214
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating CD8(+) T lymphocytes associated with clinical outcome in anal squamous cell carcinoma.
Hu WH; Miyai K; Cajas-Monson LC; Luo L; Liu L; Ramamoorthy SL
J Surg Oncol; 2015 Sep; 112(4):421-6. PubMed ID: 26287957
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.
Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM
Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656
[TBL] [Abstract][Full Text] [Related]
9. Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.
Trilla-Fuertes L; Gámez-Pozo A; Maurel J; Garcia-Carbonero R; Capdevila J; G-Pastrián L; Mendiola M; Peña C; López-Vacas R; Cuatrecasas M; García-Alfonso P; Ramos-Ruiz R; Llorens C; Ghanem I; Conill C; Heredia-Soto V; Campos-Barros Á; Fresno Vara JÁ; Feliu J
Sci Rep; 2021 Apr; 11(1):7402. PubMed ID: 33795829
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.
Williams M; Swampillai A; Osborne M; Mawdsley S; Hughes R; Harrison M; Harvey R; Glynne-Jones R;
Cancer; 2013 Jul; 119(13):2391-8. PubMed ID: 23576077
[TBL] [Abstract][Full Text] [Related]
11. Molecular and genomic characterisation of a panel of human anal cancer cell lines.
Guerra GR; Kong JC; Millen RM; Read M; Liu DS; Roth S; Sampurno S; Sia J; Bernardi MP; Chittleborough TJ; Behrenbruch CC; Teh J; Xu H; Haynes NM; Yu J; Lupat R; Hawkes D; Di Costanzo N; Tothill RW; Mitchell C; Ngan SY; Heriot AG; Ramsay RG; Phillips WA
Cell Death Dis; 2021 Oct; 12(11):959. PubMed ID: 34663790
[TBL] [Abstract][Full Text] [Related]
12. Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer.
Gilbert DC; Serup-Hansen E; Linnemann D; Høgdall E; Bailey C; Summers J; Havsteen H; Thomas GJ
Br J Cancer; 2016 Jan; 114(2):134-7. PubMed ID: 26730577
[TBL] [Abstract][Full Text] [Related]
13. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
[TBL] [Abstract][Full Text] [Related]
14. Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy.
Yanik EL; Kaunitz GJ; Cottrell TR; Succaria F; McMiller TL; Ascierto ML; Esandrio J; Xu H; Ogurtsova A; Cornish T; Lipson EJ; Topalian SL; Engels EA; Taube JM
JAMA Oncol; 2017 Jul; 3(7):974-978. PubMed ID: 28334399
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
[TBL] [Abstract][Full Text] [Related]
16. Squamous-cell carcinoma of the anus with high intratumoral lymphocytosis and its clinical implications.
Rubio CA; Nilsson PJ
Anticancer Res; 2008; 28(4C):2469-72. PubMed ID: 18751436
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma.
Grabenbauer GG; Lahmer G; Distel L; Niedobitek G
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3355-60. PubMed ID: 16740757
[TBL] [Abstract][Full Text] [Related]
18. p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy.
Gilbert DC; Williams A; Allan K; Stokoe J; Jackson T; Linsdall S; Bailey CM; Summers J
Radiother Oncol; 2013 Oct; 109(1):146-51. PubMed ID: 24021343
[TBL] [Abstract][Full Text] [Related]
19. Low mutation percentage of KRAS and BRAF genes in Brazilian anal tumors.
Bidinotto LT; Véo CA; Loaiza EA; De França AP; Lorenzi AT; Rosa LA; De Oliveira CM; Levi JE; Scapulatempo-Neto C; Longatto-Filho A; Reis RM
Mol Med Rep; 2016 Oct; 14(4):3791-7. PubMed ID: 27573925
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
Morris VK; Rashid A; Rodriguez-Bigas M; Das P; Chang G; Ohinata A; Rogers J; Crane C; Wolff RA; Eng C
Oncologist; 2015 Nov; 20(11):1247-52. PubMed ID: 26382740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
